Skip to main content

Table 2 Agreement for presence of selected comorbidities between medical chart and administrative data

From: (Dis)concordance of comorbidity data and cancer status across administrative datasets, medical charts, and self-reports

 

Comorbidity

Medical chart data n, (%)

Administrative data n, (%)

Percentage agreement %, (95% CI)

κ statistic (95% CI)

Data available for all six study sites (n = 201)

Myocardial infarction

Congestive heart failure

6 (3.0)

0 (0)

97 (95–99)

0 (0–0)

Diabetes without chronic complications

Diabetes with chronic complications

21 (10.5)

17 (8.5)

94 (90–97)

0.61 (0.42–0.81)

Mild liver disease

Moderate or severe liver disease

3 (1.5)

1 (0)

99 (97–100)

0 (0–0)

Any malignancya

Metastatic solid tumour

201 (100)

201 (100)

NC

NC

Rheumatic diseaseb

4 (2.0)

(0)

98 (96–100)

(0–0)

Ulcer or stomach disease

3 (1.5)

0 (0)

99 (97–100)

0 (0–0)

Renal disease

4 (2.0)

1 (0.5)

98 (95–100)

−0.01 (−0.02–0.00)

Chronic pulmonary disease

26 (12.9)

0 (0)

88 (83–92)

0 (0–0)

Hemiplegia

0 (0)

0 (0)

NC

NC

AIDS/HIV

0 (0)

0 (0)

NC

NC

Peripheral vascular disease

1 (0.5)

0 (0)

100 (99–100)

0 (0–0)

Dementia

0 (0)

0 (0)

NC

NC

Cerebrovascular disease

5 (2.5)

0 (0)

98 (96–100)

0 (0–0)

Data available for all sites except site 1 (n = 172)

High blood pressure

81 (47.1)

72 (41.9)

87 (81–92)

0.73 (0.63–0.83)

Anaemia or other blood disease

7 (4.1)

9 (5.2)

93 (89–97)

0.21 (−0.08–0.51)

Depression

6 (3.5)

0 (0)

97 (94–99)

0 (0–0)

Back pain

7 (4.1)

0 (0)

96 (93–99)

0 (0–0)

Osteoarthritis/ degenerative arthritis

17 (9.9)

9 (5.2)

93 (89–97)

0.50 (0.26–0.75)

 

Total count

392

310

  
  1. NC not calculable (prevalence was either 0% or 100%)
  2. aincludes leukaemia and lymphoma
  3. bsame as connective tissue disorders